Phase I trial of AE-37 in patients with breast cancer.
Phase of Trial: Phase I
Latest Information Update: 23 Jun 2008
At a glance
- Drugs AE 37 (Primary)
- Indications Breast cancer
- Focus Pharmacodynamics
- Sponsors Generex Biotechnology Corporation
- 23 Jun 2008 Results will be published in the Journal of Clinical Oncology.
- 03 Jun 2008 Final results presented at the Annual Meeting of the American Society of Clinical Oncology 2008.
- 17 Dec 2006 Results have been reported.